Global WuXi Webinar: Pioneering Approaches to Dismantling Cancer

Significant advances have been made to unravel cancer’s mysteries and complexities at the genetic, molecular, and pathway levels. These advances not only reveal new scientific insights into the biology of the...

Over 1,100 Executives Signed-up for 4th Annual WuXi Global Forum at J.P. Morgan Conference

On January 12 in San Francisco, WuXi hosted our 4th Annual WuXi Global Forum – A Celebration of Global Partnerships.   This year’s WuXi Global Forum opened to a packed house, bringing...

WuXi and MedImmune Form a Strategic Alliance to Develop Innovative Biologics in China for...

We are pleased to announce that we have formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca to bring cutting-edge research and technical capability for...

WuXi and Lilly Collaborate to Develop Novel Therapeutics in China

We are pleased to share with you that we have entered into a strategic collaboration with Eli Lilly and Company to develop, manufacture and commercialize a novel small molecule in China...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

China Market Authorization Holder System Summit 2017 Recap

More than 300 professionals gathered at the recent China Marketing Authorization Holder (MAH) System Summit to learn from government agencies, life science research and...